
Bintax S 250mg/125mg Injection
Marketer
Bionet India Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Bintax S 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be strictly under a physician's guidance. Consistent adherence to the prescribed dosage is crucial; premature cessation can compromise treatment efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects necessitate immediate medical attention. Allergic reactions (skin rashes, pruritus, edema, dyspnea) demand immediate emergency care. Inform your doctor of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally not impairing driving ability, drowsiness or dizziness warrants abstaining from driving. Ample rest, a nutritious diet, and hydration are recommended for optimal recovery. Your doctor may order blood tests and other diagnostics to monitor therapeutic response.
Primary Ingredients of Bintax S 250mg/125mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Bintax S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Bintax S 250mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Bintax S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Bintax S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Bintax S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Bintax S 250mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The addition of Sulbactam, a beta-lactamase inhibitor, overcomes bacterial resistance mechanisms, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Bintax S 250mg/125mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Bintax S 250mg/125mg is typically deemed safe for use during gestation. Preclinical trials using animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human subjects are scarce.
Breast feedingCAUTION
The administration of Bintax S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Bintax S 250mg/125mg Injection can lead to reduced awareness, visual disturbances, drowsiness, and dizziness. Refrain from operating a vehicle should any of these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Bintax S 250mg/125mg Injection to individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
Exercise caution when administering Bintax S 250mg/125mg Injection to individuals with significant hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alterations for Bintax S 250mg/125mg Injection are unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Bintax S 250mg/125mg Injection :
Should you forget a scheduled injection of Bintax S 250mg/125mg, seek medical advice immediately.
Facts to Know About Bintax S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
